ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 524 participants.

Also called NCT02574481

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 524 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02574481
Other papers using this trial's data
  • 24-Month Efficacy and Safety Results from Japanese Patients in the IMPERIAL Randomized Study of the Eluvia Drug-Eluting Stent and the Zilver PTX Drug-Coated Stent Cardiovascular and interventional radiology, 2021-09 DOI, PubMed 34235560, PMC8382620 In the PMC Open Access subset under CC BY.
  • A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial Lancet (London, England), 2018-10-27 DOI, PubMed 30262332
  • Japanese Patients Treated in the IMPERIAL Randomized Trial Comparing Eluvia and Zilver PTX Stents Cardiovascular and interventional radiology, 2020-02 DOI, PubMed 31690980
  • Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent Cardiovascular and interventional radiology, 2021-03 DOI, PubMed 33225377

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Belgium, Canada, Germany, Japan, New Zealand (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02574481. Randomized; single masking; primary purpose treatment. Start 2015-12 (actual); primary completion 2017-12-28 (actual). Results posted on 2019-01-07.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent
Acronym
IMPERIAL
Condition
Atherosclerosis of Native Arteries of the Extremities
Intervention (Device)
ELUVIA (Stent Implantation)
Intervention (Device)
Zilver PTX (Stent Implantation)
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct02574481
Content hash
b496d501f00d7b879df8f56856933f1a1af4d433eb0e1756ef741ff6ce05397b